Synthace

About:

Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.

Website: https://www.synthace.com

Twitter/X: synthace

Top Investors: Future Planet Capital, Sofinnova Partners, SOSV, Amadeus Capital Partners, Horizons Ventures

Description:

Synthace is a digital experiment platform built for life science R&D teams to help them run more powerful experiments. It digitizes experiments from end to end: with minimal training, scientists can design and plan reproducible experiments, simulate them ahead of time, run them on their automation equipment, and automatically structure all of their experimental data and metadata in a single place. Controlled from a browser window and needing no code to operate, it makes experiments easier to run in the lab, increases the scientific value of experiments, and also makes it possible to run experiments that were previously thought impossible.